metastasis of prostate cancer cancer metastasis b
ewer targeted therapies include: Androgen receptor inhibitors (e.g., enzalutamide, apalutamide) PARP inhibitors for patients with specific genetic mutations Bone-Targeted Treatments Given the prevalence of bone metastases, treatments su
